nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—CA9—hematologic cancer	0.345	1	CbGaD
Metolazone—CA7—Imatinib—hematologic cancer	0.072	0.17	CbGbCtD
Metolazone—CA7—Nilotinib—hematologic cancer	0.0655	0.155	CbGbCtD
Metolazone—CA12—Imatinib—hematologic cancer	0.0618	0.146	CbGbCtD
Metolazone—CA9—Imatinib—hematologic cancer	0.0618	0.146	CbGbCtD
Metolazone—CA9—Nilotinib—hematologic cancer	0.0562	0.133	CbGbCtD
Metolazone—CA12—Nilotinib—hematologic cancer	0.0562	0.133	CbGbCtD
Metolazone—CA4—Nilotinib—hematologic cancer	0.0494	0.117	CbGbCtD
Metolazone—Benzthiazide—CA9—hematologic cancer	0.000706	0.351	CrCbGaD
Metolazone—Indapamide—CA9—hematologic cancer	0.0007	0.349	CrCbGaD
Metolazone—Chlorthalidone—CA9—hematologic cancer	0.000603	0.3	CrCbGaD
Metolazone—CA5B—hematopoietic system—hematologic cancer	0.000236	0.12	CbGeAlD
Metolazone—SLC12A3—lung—hematologic cancer	0.000231	0.117	CbGeAlD
Metolazone—CA9—testis—hematologic cancer	0.000195	0.0989	CbGeAlD
Metolazone—CA5B—gonad—hematologic cancer	0.00018	0.0911	CbGeAlD
Metolazone—CA5B—blood—hematologic cancer	0.000156	0.0793	CbGeAlD
Metolazone—CA12—lung—hematologic cancer	0.000153	0.0775	CbGeAlD
Metolazone—CA5B—lung—hematologic cancer	0.000137	0.0696	CbGeAlD
Metolazone—CA5B—testis—hematologic cancer	0.000129	0.0656	CbGeAlD
Metolazone—CA4—blood—hematologic cancer	0.000108	0.0548	CbGeAlD
Metolazone—CA4—bone marrow—hematologic cancer	0.000105	0.053	CbGeAlD
Metolazone—CA4—lung—hematologic cancer	9.47e-05	0.048	CbGeAlD
Metolazone—CA5B—lymph node—hematologic cancer	9.38e-05	0.0476	CbGeAlD
Metolazone—CA4—testis—hematologic cancer	8.93e-05	0.0453	CbGeAlD
Metolazone—CA4—lymph node—hematologic cancer	6.48e-05	0.0328	CbGeAlD
Metolazone—CA12—Metabolism—NCOR2—hematologic cancer	3.86e-05	0.00114	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAPK14—hematologic cancer	3.85e-05	0.00113	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CRABP1—hematologic cancer	3.85e-05	0.00113	CbGpPWpGaD
Metolazone—CA5A—Metabolism—SLC22A1—hematologic cancer	3.85e-05	0.00113	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SPHK1—hematologic cancer	3.85e-05	0.00113	CbGpPWpGaD
Metolazone—CA7—Metabolism—SPHK1—hematologic cancer	3.85e-05	0.00113	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—ATM—hematologic cancer	3.81e-05	0.00112	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CDK4—hematologic cancer	3.79e-05	0.00112	CbGpPWpGaD
Metolazone—CA9—Metabolism—PC—hematologic cancer	3.77e-05	0.00111	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALOX5—hematologic cancer	3.75e-05	0.0011	CbGpPWpGaD
Metolazone—CA5B—Metabolism—UGT1A1—hematologic cancer	3.69e-05	0.00109	CbGpPWpGaD
Metolazone—CA7—Metabolism—UGT1A1—hematologic cancer	3.69e-05	0.00109	CbGpPWpGaD
Metolazone—CA12—Metabolism—IDH1—hematologic cancer	3.68e-05	0.00108	CbGpPWpGaD
Metolazone—CA4—Metabolism—FHL2—hematologic cancer	3.67e-05	0.00108	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.66e-05	0.00108	CbGpPWpGaD
Metolazone—CA9—Metabolism—GBA—hematologic cancer	3.64e-05	0.00107	CbGpPWpGaD
Metolazone—CA12—Metabolism—TXN—hematologic cancer	3.64e-05	0.00107	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTO1—hematologic cancer	3.64e-05	0.00107	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCC3—hematologic cancer	3.64e-05	0.00107	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC35B2—hematologic cancer	3.64e-05	0.00107	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NUP98—hematologic cancer	3.63e-05	0.00107	CbGpPWpGaD
Metolazone—CA4—Metabolism—AGRN—hematologic cancer	3.6e-05	0.00106	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CRABP1—hematologic cancer	3.59e-05	0.00106	CbGpPWpGaD
Metolazone—CA7—Metabolism—SLC22A1—hematologic cancer	3.59e-05	0.00106	CbGpPWpGaD
Metolazone—CA7—Metabolism—CRABP1—hematologic cancer	3.59e-05	0.00106	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SLC22A1—hematologic cancer	3.59e-05	0.00106	CbGpPWpGaD
Metolazone—CA12—Metabolism—SPHK1—hematologic cancer	3.56e-05	0.00105	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ADCY7—hematologic cancer	3.53e-05	0.00104	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NCOA3—hematologic cancer	3.53e-05	0.00104	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALOX5—hematologic cancer	3.5e-05	0.00103	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NUP214—hematologic cancer	3.5e-05	0.00103	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALOX5—hematologic cancer	3.5e-05	0.00103	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ABCG2—hematologic cancer	3.43e-05	0.00101	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MTR—hematologic cancer	3.43e-05	0.00101	CbGpPWpGaD
Metolazone—CA12—Metabolism—UGT1A1—hematologic cancer	3.42e-05	0.00101	CbGpPWpGaD
Metolazone—CA4—Metabolism—IDH2—hematologic cancer	3.41e-05	0.001	CbGpPWpGaD
Metolazone—CA4—Metabolism—HMMR—hematologic cancer	3.41e-05	0.001	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—FOS—hematologic cancer	3.4e-05	0.001	CbGpPWpGaD
Metolazone—CA7—Metabolism—NUP98—hematologic cancer	3.39e-05	0.000998	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NUP98—hematologic cancer	3.39e-05	0.000998	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ENO2—hematologic cancer	3.37e-05	0.00099	CbGpPWpGaD
Metolazone—CA12—Metabolism—SLC22A1—hematologic cancer	3.33e-05	0.00098	CbGpPWpGaD
Metolazone—CA12—Metabolism—CRABP1—hematologic cancer	3.33e-05	0.00098	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTAP—hematologic cancer	3.33e-05	0.00098	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CREBBP—hematologic cancer	3.31e-05	0.000974	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—RB1—hematologic cancer	3.3e-05	0.000971	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ADCY7—hematologic cancer	3.29e-05	0.000969	CbGpPWpGaD
Metolazone—CA7—Metabolism—ADCY7—hematologic cancer	3.29e-05	0.000969	CbGpPWpGaD
Metolazone—CA7—Metabolism—NCOA3—hematologic cancer	3.29e-05	0.000969	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NCOA3—hematologic cancer	3.29e-05	0.000969	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NUP214—hematologic cancer	3.27e-05	0.000962	CbGpPWpGaD
Metolazone—CA7—Metabolism—NUP214—hematologic cancer	3.27e-05	0.000962	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTT1—hematologic cancer	3.26e-05	0.00096	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALOX5—hematologic cancer	3.24e-05	0.000955	CbGpPWpGaD
Metolazone—CA4—Metabolism—ARNTL—hematologic cancer	3.21e-05	0.000945	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCG2—hematologic cancer	3.2e-05	0.000943	CbGpPWpGaD
Metolazone—CA7—Metabolism—MTR—hematologic cancer	3.2e-05	0.000943	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCG2—hematologic cancer	3.2e-05	0.000943	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MTR—hematologic cancer	3.2e-05	0.000943	CbGpPWpGaD
Metolazone—CA5A—Metabolism—SDC1—hematologic cancer	3.19e-05	0.000939	CbGpPWpGaD
Metolazone—Headache—Irinotecan—hematologic cancer	3.18e-05	0.000164	CcSEcCtD
Metolazone—Headache—Mitoxantrone—hematologic cancer	3.18e-05	0.000164	CcSEcCtD
Metolazone—Nausea—Ifosfamide—hematologic cancer	3.17e-05	0.000163	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.16e-05	0.000163	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.16e-05	0.000163	CcSEcCtD
Metolazone—Arthralgia—Prednisone—hematologic cancer	3.15e-05	0.000162	CcSEcCtD
Metolazone—Feeling abnormal—Triamcinolone—hematologic cancer	3.15e-05	0.000162	CcSEcCtD
Metolazone—Diarrhoea—Cisplatin—hematologic cancer	3.15e-05	0.000162	CcSEcCtD
Metolazone—Erythema multiforme—Epirubicin—hematologic cancer	3.14e-05	0.000162	CcSEcCtD
Metolazone—CA12—Metabolism—NUP98—hematologic cancer	3.14e-05	0.000925	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ENO2—hematologic cancer	3.14e-05	0.000924	CbGpPWpGaD
Metolazone—CA7—Metabolism—ENO2—hematologic cancer	3.14e-05	0.000924	CbGpPWpGaD
Metolazone—Anxiety—Prednisone—hematologic cancer	3.14e-05	0.000162	CcSEcCtD
Metolazone—Vomiting—Gemcitabine—hematologic cancer	3.14e-05	0.000162	CcSEcCtD
Metolazone—Insomnia—Dexamethasone—hematologic cancer	3.14e-05	0.000162	CcSEcCtD
Metolazone—Insomnia—Betamethasone—hematologic cancer	3.14e-05	0.000162	CcSEcCtD
Metolazone—CA4—Metabolism—CA9—hematologic cancer	3.12e-05	0.000919	CbGpPWpGaD
Metolazone—CA4—Metabolism—ACP5—hematologic cancer	3.12e-05	0.000919	CbGpPWpGaD
Metolazone—Paraesthesia—Dexamethasone—hematologic cancer	3.12e-05	0.00016	CcSEcCtD
Metolazone—Paraesthesia—Betamethasone—hematologic cancer	3.12e-05	0.00016	CcSEcCtD
Metolazone—Discomfort—Prednisone—hematologic cancer	3.11e-05	0.00016	CcSEcCtD
Metolazone—Rash—Gemcitabine—hematologic cancer	3.11e-05	0.00016	CcSEcCtD
Metolazone—Dermatitis—Gemcitabine—hematologic cancer	3.11e-05	0.00016	CcSEcCtD
Metolazone—Hypersensitivity—Etoposide—hematologic cancer	3.11e-05	0.00016	CcSEcCtD
Metolazone—Tinnitus—Epirubicin—hematologic cancer	3.1e-05	0.00016	CcSEcCtD
Metolazone—Headache—Gemcitabine—hematologic cancer	3.09e-05	0.000159	CcSEcCtD
Metolazone—Nausea—Vincristine—hematologic cancer	3.09e-05	0.000159	CcSEcCtD
Metolazone—CA4—Metabolism—NCOR2—hematologic cancer	3.08e-05	0.000907	CbGpPWpGaD
Metolazone—Hepatitis—Doxorubicin—hematologic cancer	3.08e-05	0.000159	CcSEcCtD
Metolazone—Hypersensitivity—Prednisolone—hematologic cancer	3.06e-05	0.000158	CcSEcCtD
Metolazone—Dyspepsia—Dexamethasone—hematologic cancer	3.05e-05	0.000157	CcSEcCtD
Metolazone—Dyspepsia—Betamethasone—hematologic cancer	3.05e-05	0.000157	CcSEcCtD
Metolazone—CA12—Metabolism—ADCY7—hematologic cancer	3.05e-05	0.000898	CbGpPWpGaD
Metolazone—CA12—Metabolism—NCOA3—hematologic cancer	3.05e-05	0.000898	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTT1—hematologic cancer	3.05e-05	0.000897	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTT1—hematologic cancer	3.05e-05	0.000897	CbGpPWpGaD
Metolazone—Urticaria—Triamcinolone—hematologic cancer	3.04e-05	0.000156	CcSEcCtD
Metolazone—Dysgeusia—Methotrexate—hematologic cancer	3.03e-05	0.000156	CcSEcCtD
Metolazone—CA12—Metabolism—NUP214—hematologic cancer	3.03e-05	0.000891	CbGpPWpGaD
Metolazone—Asthenia—Etoposide—hematologic cancer	3.02e-05	0.000156	CcSEcCtD
Metolazone—Decreased appetite—Betamethasone—hematologic cancer	3.02e-05	0.000155	CcSEcCtD
Metolazone—Decreased appetite—Dexamethasone—hematologic cancer	3.02e-05	0.000155	CcSEcCtD
Metolazone—Nausea—Irinotecan—hematologic cancer	3.01e-05	0.000155	CcSEcCtD
Metolazone—Nausea—Mitoxantrone—hematologic cancer	3.01e-05	0.000155	CcSEcCtD
Metolazone—Back pain—Methotrexate—hematologic cancer	2.99e-05	0.000154	CcSEcCtD
Metolazone—Fatigue—Dexamethasone—hematologic cancer	2.99e-05	0.000154	CcSEcCtD
Metolazone—Fatigue—Betamethasone—hematologic cancer	2.99e-05	0.000154	CcSEcCtD
Metolazone—Chills—Epirubicin—hematologic cancer	2.98e-05	0.000154	CcSEcCtD
Metolazone—Pruritus—Etoposide—hematologic cancer	2.98e-05	0.000154	CcSEcCtD
Metolazone—CA5B—Metabolism—SDC1—hematologic cancer	2.98e-05	0.000876	CbGpPWpGaD
Metolazone—CA7—Metabolism—SDC1—hematologic cancer	2.98e-05	0.000876	CbGpPWpGaD
Metolazone—Shock—Prednisone—hematologic cancer	2.97e-05	0.000153	CcSEcCtD
Metolazone—CA12—Metabolism—MTR—hematologic cancer	2.97e-05	0.000873	CbGpPWpGaD
Metolazone—CA9—Metabolism—FHL2—hematologic cancer	2.97e-05	0.000873	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCG2—hematologic cancer	2.97e-05	0.000873	CbGpPWpGaD
Metolazone—Pain—Betamethasone—hematologic cancer	2.97e-05	0.000153	CcSEcCtD
Metolazone—Pain—Dexamethasone—hematologic cancer	2.97e-05	0.000153	CcSEcCtD
Metolazone—CA4—Metabolism—IDH1—hematologic cancer	2.94e-05	0.000864	CbGpPWpGaD
Metolazone—Nausea—Gemcitabine—hematologic cancer	2.93e-05	0.000151	CcSEcCtD
Metolazone—Vomiting—Cisplatin—hematologic cancer	2.93e-05	0.000151	CcSEcCtD
Metolazone—Vision blurred—Methotrexate—hematologic cancer	2.92e-05	0.00015	CcSEcCtD
Metolazone—CA9—Metabolism—AGRN—hematologic cancer	2.91e-05	0.000856	CbGpPWpGaD
Metolazone—CA12—Metabolism—ENO2—hematologic cancer	2.91e-05	0.000856	CbGpPWpGaD
Metolazone—Erythema multiforme—Doxorubicin—hematologic cancer	2.91e-05	0.00015	CcSEcCtD
Metolazone—CA4—Metabolism—GSTO1—hematologic cancer	2.9e-05	0.000854	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCC3—hematologic cancer	2.9e-05	0.000854	CbGpPWpGaD
Metolazone—CA4—Metabolism—TXN—hematologic cancer	2.9e-05	0.000854	CbGpPWpGaD
Metolazone—Rash—Cisplatin—hematologic cancer	2.9e-05	0.000149	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—CDKN2A—hematologic cancer	2.9e-05	0.000853	CbGpPWpGaD
Metolazone—Dermatitis—Cisplatin—hematologic cancer	2.9e-05	0.000149	CcSEcCtD
Metolazone—Diarrhoea—Etoposide—hematologic cancer	2.88e-05	0.000149	CcSEcCtD
Metolazone—Anorexia—Prednisone—hematologic cancer	2.88e-05	0.000148	CcSEcCtD
Metolazone—Ill-defined disorder—Methotrexate—hematologic cancer	2.87e-05	0.000148	CcSEcCtD
Metolazone—Tinnitus—Doxorubicin—hematologic cancer	2.87e-05	0.000148	CcSEcCtD
Metolazone—Anaemia—Methotrexate—hematologic cancer	2.86e-05	0.000147	CcSEcCtD
Metolazone—Feeling abnormal—Dexamethasone—hematologic cancer	2.86e-05	0.000147	CcSEcCtD
Metolazone—Feeling abnormal—Betamethasone—hematologic cancer	2.86e-05	0.000147	CcSEcCtD
Metolazone—Flatulence—Epirubicin—hematologic cancer	2.85e-05	0.000147	CcSEcCtD
Metolazone—Tension—Epirubicin—hematologic cancer	2.84e-05	0.000146	CcSEcCtD
Metolazone—CA4—Metabolism—SPHK1—hematologic cancer	2.84e-05	0.000836	CbGpPWpGaD
Metolazone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.84e-05	0.000146	CcSEcCtD
Metolazone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.84e-05	0.000146	CcSEcCtD
Metolazone—Dysgeusia—Epirubicin—hematologic cancer	2.84e-05	0.000146	CcSEcCtD
Metolazone—CA12—Metabolism—GSTT1—hematologic cancer	2.82e-05	0.000831	CbGpPWpGaD
Metolazone—Hypersensitivity—Triamcinolone—hematologic cancer	2.82e-05	0.000145	CcSEcCtD
Metolazone—Nervousness—Epirubicin—hematologic cancer	2.81e-05	0.000145	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—MDM2—hematologic cancer	2.81e-05	0.000827	CbGpPWpGaD
Metolazone—Back pain—Epirubicin—hematologic cancer	2.8e-05	0.000144	CcSEcCtD
Metolazone—Malaise—Methotrexate—hematologic cancer	2.79e-05	0.000144	CcSEcCtD
Metolazone—Dizziness—Etoposide—hematologic cancer	2.79e-05	0.000144	CcSEcCtD
Metolazone—Muscle spasms—Epirubicin—hematologic cancer	2.78e-05	0.000143	CcSEcCtD
Metolazone—Vertigo—Methotrexate—hematologic cancer	2.78e-05	0.000143	CcSEcCtD
Metolazone—Leukopenia—Methotrexate—hematologic cancer	2.77e-05	0.000143	CcSEcCtD
Metolazone—Chills—Doxorubicin—hematologic cancer	2.76e-05	0.000142	CcSEcCtD
Metolazone—CA12—Metabolism—SDC1—hematologic cancer	2.76e-05	0.000812	CbGpPWpGaD
Metolazone—CA9—Metabolism—HMMR—hematologic cancer	2.76e-05	0.000812	CbGpPWpGaD
Metolazone—CA9—Metabolism—IDH2—hematologic cancer	2.76e-05	0.000812	CbGpPWpGaD
Metolazone—Urticaria—Dexamethasone—hematologic cancer	2.76e-05	0.000142	CcSEcCtD
Metolazone—Urticaria—Betamethasone—hematologic cancer	2.76e-05	0.000142	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.75e-05	0.000142	CcSEcCtD
Metolazone—Dizziness—Prednisolone—hematologic cancer	2.75e-05	0.000142	CcSEcCtD
Metolazone—Asthenia—Triamcinolone—hematologic cancer	2.74e-05	0.000141	CcSEcCtD
Metolazone—Abdominal pain—Betamethasone—hematologic cancer	2.74e-05	0.000141	CcSEcCtD
Metolazone—Abdominal pain—Dexamethasone—hematologic cancer	2.74e-05	0.000141	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—MTOR—hematologic cancer	2.74e-05	0.000805	CbGpPWpGaD
Metolazone—Nausea—Cisplatin—hematologic cancer	2.73e-05	0.000141	CcSEcCtD
Metolazone—Insomnia—Prednisone—hematologic cancer	2.73e-05	0.000141	CcSEcCtD
Metolazone—CA4—Metabolism—UGT1A1—hematologic cancer	2.73e-05	0.000803	CbGpPWpGaD
Metolazone—Vision blurred—Epirubicin—hematologic cancer	2.73e-05	0.000141	CcSEcCtD
Metolazone—Paraesthesia—Prednisone—hematologic cancer	2.71e-05	0.00014	CcSEcCtD
Metolazone—CA5A—Metabolism—NQO1—hematologic cancer	2.71e-05	0.000798	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CD44—hematologic cancer	2.71e-05	0.000798	CbGpPWpGaD
Metolazone—Pruritus—Triamcinolone—hematologic cancer	2.71e-05	0.000139	CcSEcCtD
Metolazone—Cough—Methotrexate—hematologic cancer	2.7e-05	0.000139	CcSEcCtD
Metolazone—Ill-defined disorder—Epirubicin—hematologic cancer	2.69e-05	0.000138	CcSEcCtD
Metolazone—Vomiting—Etoposide—hematologic cancer	2.68e-05	0.000138	CcSEcCtD
Metolazone—Anaemia—Epirubicin—hematologic cancer	2.68e-05	0.000138	CcSEcCtD
Metolazone—Agitation—Epirubicin—hematologic cancer	2.66e-05	0.000137	CcSEcCtD
Metolazone—Dyspepsia—Prednisone—hematologic cancer	2.66e-05	0.000137	CcSEcCtD
Metolazone—Rash—Etoposide—hematologic cancer	2.66e-05	0.000137	CcSEcCtD
Metolazone—Dermatitis—Etoposide—hematologic cancer	2.66e-05	0.000137	CcSEcCtD
Metolazone—CA4—Metabolism—SLC22A1—hematologic cancer	2.66e-05	0.000781	CbGpPWpGaD
Metolazone—CA4—Metabolism—CRABP1—hematologic cancer	2.66e-05	0.000781	CbGpPWpGaD
Metolazone—Headache—Etoposide—hematologic cancer	2.64e-05	0.000136	CcSEcCtD
Metolazone—Flatulence—Doxorubicin—hematologic cancer	2.64e-05	0.000136	CcSEcCtD
Metolazone—Arthralgia—Methotrexate—hematologic cancer	2.63e-05	0.000136	CcSEcCtD
Metolazone—Chest pain—Methotrexate—hematologic cancer	2.63e-05	0.000136	CcSEcCtD
Metolazone—Tension—Doxorubicin—hematologic cancer	2.63e-05	0.000135	CcSEcCtD
Metolazone—Decreased appetite—Prednisone—hematologic cancer	2.63e-05	0.000135	CcSEcCtD
Metolazone—Dysgeusia—Doxorubicin—hematologic cancer	2.62e-05	0.000135	CcSEcCtD
Metolazone—Rash—Prednisolone—hematologic cancer	2.62e-05	0.000135	CcSEcCtD
Metolazone—Dermatitis—Prednisolone—hematologic cancer	2.62e-05	0.000135	CcSEcCtD
Metolazone—Malaise—Epirubicin—hematologic cancer	2.61e-05	0.000134	CcSEcCtD
Metolazone—Fatigue—Prednisone—hematologic cancer	2.61e-05	0.000134	CcSEcCtD
Metolazone—Headache—Prednisolone—hematologic cancer	2.6e-05	0.000134	CcSEcCtD
Metolazone—Discomfort—Methotrexate—hematologic cancer	2.6e-05	0.000134	CcSEcCtD
Metolazone—Nervousness—Doxorubicin—hematologic cancer	2.6e-05	0.000134	CcSEcCtD
Metolazone—Vertigo—Epirubicin—hematologic cancer	2.6e-05	0.000134	CcSEcCtD
Metolazone—Syncope—Epirubicin—hematologic cancer	2.6e-05	0.000134	CcSEcCtD
Metolazone—CA9—Metabolism—ARNTL—hematologic cancer	2.59e-05	0.000763	CbGpPWpGaD
Metolazone—Leukopenia—Epirubicin—hematologic cancer	2.59e-05	0.000133	CcSEcCtD
Metolazone—Back pain—Doxorubicin—hematologic cancer	2.59e-05	0.000133	CcSEcCtD
Metolazone—CA4—Metabolism—ALOX5—hematologic cancer	2.59e-05	0.000761	CbGpPWpGaD
Metolazone—Constipation—Prednisone—hematologic cancer	2.58e-05	0.000133	CcSEcCtD
Metolazone—Muscle spasms—Doxorubicin—hematologic cancer	2.58e-05	0.000133	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—CDKN1B—hematologic cancer	2.57e-05	0.000756	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYCS—hematologic cancer	2.57e-05	0.000755	CbGpPWpGaD
Metolazone—Palpitations—Epirubicin—hematologic cancer	2.56e-05	0.000132	CcSEcCtD
Metolazone—CA5A—Metabolism—HSP90AA1—hematologic cancer	2.55e-05	0.00075	CbGpPWpGaD
Metolazone—Loss of consciousness—Epirubicin—hematologic cancer	2.54e-05	0.000131	CcSEcCtD
Metolazone—CA7—Metabolism—NQO1—hematologic cancer	2.53e-05	0.000745	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NQO1—hematologic cancer	2.53e-05	0.000745	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CD44—hematologic cancer	2.53e-05	0.000745	CbGpPWpGaD
Metolazone—CA7—Metabolism—CD44—hematologic cancer	2.53e-05	0.000745	CbGpPWpGaD
Metolazone—Dizziness—Triamcinolone—hematologic cancer	2.53e-05	0.00013	CcSEcCtD
Metolazone—Cough—Epirubicin—hematologic cancer	2.53e-05	0.00013	CcSEcCtD
Metolazone—Vision blurred—Doxorubicin—hematologic cancer	2.52e-05	0.00013	CcSEcCtD
Metolazone—CA9—Metabolism—ACP5—hematologic cancer	2.52e-05	0.000742	CbGpPWpGaD
Metolazone—CA4—Metabolism—NUP98—hematologic cancer	2.51e-05	0.000737	CbGpPWpGaD
Metolazone—Nausea—Etoposide—hematologic cancer	2.5e-05	0.000129	CcSEcCtD
Metolazone—Hypertension—Epirubicin—hematologic cancer	2.5e-05	0.000129	CcSEcCtD
Metolazone—CA9—Metabolism—NCOR2—hematologic cancer	2.49e-05	0.000733	CbGpPWpGaD
Metolazone—Feeling abnormal—Prednisone—hematologic cancer	2.49e-05	0.000128	CcSEcCtD
Metolazone—Asthenia—Dexamethasone—hematologic cancer	2.49e-05	0.000128	CcSEcCtD
Metolazone—Asthenia—Betamethasone—hematologic cancer	2.49e-05	0.000128	CcSEcCtD
Metolazone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.49e-05	0.000128	CcSEcCtD
Metolazone—Anaemia—Doxorubicin—hematologic cancer	2.48e-05	0.000128	CcSEcCtD
Metolazone—Thrombocytopenia—Methotrexate—hematologic cancer	2.47e-05	0.000127	CcSEcCtD
Metolazone—Gastrointestinal pain—Prednisone—hematologic cancer	2.47e-05	0.000127	CcSEcCtD
Metolazone—Nausea—Prednisolone—hematologic cancer	2.47e-05	0.000127	CcSEcCtD
Metolazone—Chest pain—Epirubicin—hematologic cancer	2.47e-05	0.000127	CcSEcCtD
Metolazone—Arthralgia—Epirubicin—hematologic cancer	2.47e-05	0.000127	CcSEcCtD
Metolazone—Agitation—Doxorubicin—hematologic cancer	2.46e-05	0.000127	CcSEcCtD
Metolazone—Anxiety—Epirubicin—hematologic cancer	2.46e-05	0.000127	CcSEcCtD
Metolazone—Pruritus—Betamethasone—hematologic cancer	2.45e-05	0.000126	CcSEcCtD
Metolazone—Pruritus—Dexamethasone—hematologic cancer	2.45e-05	0.000126	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—JUN—hematologic cancer	2.44e-05	0.000719	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.44e-05	0.000719	CbGpPWpGaD
Metolazone—Discomfort—Epirubicin—hematologic cancer	2.44e-05	0.000125	CcSEcCtD
Metolazone—CA4—Metabolism—ADCY7—hematologic cancer	2.43e-05	0.000716	CbGpPWpGaD
Metolazone—CA4—Metabolism—NCOA3—hematologic cancer	2.43e-05	0.000716	CbGpPWpGaD
Metolazone—Vomiting—Triamcinolone—hematologic cancer	2.43e-05	0.000125	CcSEcCtD
Metolazone—Malaise—Doxorubicin—hematologic cancer	2.42e-05	0.000124	CcSEcCtD
Metolazone—CA4—Metabolism—NUP214—hematologic cancer	2.42e-05	0.000711	CbGpPWpGaD
Metolazone—Rash—Triamcinolone—hematologic cancer	2.41e-05	0.000124	CcSEcCtD
Metolazone—Dry mouth—Epirubicin—hematologic cancer	2.41e-05	0.000124	CcSEcCtD
Metolazone—Dermatitis—Triamcinolone—hematologic cancer	2.41e-05	0.000124	CcSEcCtD
Metolazone—Vertigo—Doxorubicin—hematologic cancer	2.41e-05	0.000124	CcSEcCtD
Metolazone—Anorexia—Methotrexate—hematologic cancer	2.41e-05	0.000124	CcSEcCtD
Metolazone—Syncope—Doxorubicin—hematologic cancer	2.4e-05	0.000124	CcSEcCtD
Metolazone—Urticaria—Prednisone—hematologic cancer	2.4e-05	0.000124	CcSEcCtD
Metolazone—Leukopenia—Doxorubicin—hematologic cancer	2.4e-05	0.000124	CcSEcCtD
Metolazone—CA7—Metabolism—CYCS—hematologic cancer	2.4e-05	0.000705	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYCS—hematologic cancer	2.4e-05	0.000705	CbGpPWpGaD
Metolazone—Headache—Triamcinolone—hematologic cancer	2.4e-05	0.000123	CcSEcCtD
Metolazone—Abdominal pain—Prednisone—hematologic cancer	2.39e-05	0.000123	CcSEcCtD
Metolazone—CA7—Metabolism—HSP90AA1—hematologic cancer	2.38e-05	0.000701	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HSP90AA1—hematologic cancer	2.38e-05	0.000701	CbGpPWpGaD
Metolazone—Diarrhoea—Betamethasone—hematologic cancer	2.37e-05	0.000122	CcSEcCtD
Metolazone—Diarrhoea—Dexamethasone—hematologic cancer	2.37e-05	0.000122	CcSEcCtD
Metolazone—CA9—Metabolism—IDH1—hematologic cancer	2.37e-05	0.000698	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CDKN1A—hematologic cancer	2.37e-05	0.000697	CbGpPWpGaD
Metolazone—Palpitations—Doxorubicin—hematologic cancer	2.37e-05	0.000122	CcSEcCtD
Metolazone—CA4—Metabolism—MTR—hematologic cancer	2.37e-05	0.000696	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCG2—hematologic cancer	2.37e-05	0.000696	CbGpPWpGaD
Metolazone—Loss of consciousness—Doxorubicin—hematologic cancer	2.35e-05	0.000121	CcSEcCtD
Metolazone—CA9—Metabolism—GSTO1—hematologic cancer	2.35e-05	0.00069	CbGpPWpGaD
Metolazone—CA9—Metabolism—TXN—hematologic cancer	2.35e-05	0.00069	CbGpPWpGaD
Metolazone—CA12—Metabolism—CD44—hematologic cancer	2.35e-05	0.00069	CbGpPWpGaD
Metolazone—CA12—Metabolism—NQO1—hematologic cancer	2.35e-05	0.00069	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCC3—hematologic cancer	2.35e-05	0.00069	CbGpPWpGaD
Metolazone—Cough—Doxorubicin—hematologic cancer	2.34e-05	0.00012	CcSEcCtD
Metolazone—Shock—Epirubicin—hematologic cancer	2.32e-05	0.00012	CcSEcCtD
Metolazone—CA4—Metabolism—ENO2—hematologic cancer	2.32e-05	0.000683	CbGpPWpGaD
Metolazone—Thrombocytopenia—Epirubicin—hematologic cancer	2.31e-05	0.000119	CcSEcCtD
Metolazone—Hypertension—Doxorubicin—hematologic cancer	2.31e-05	0.000119	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—MAPK8—hematologic cancer	2.31e-05	0.000681	CbGpPWpGaD
Metolazone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.3e-05	0.000118	CcSEcCtD
Metolazone—CA9—Metabolism—SPHK1—hematologic cancer	2.3e-05	0.000676	CbGpPWpGaD
Metolazone—Dizziness—Betamethasone—hematologic cancer	2.29e-05	0.000118	CcSEcCtD
Metolazone—Dizziness—Dexamethasone—hematologic cancer	2.29e-05	0.000118	CcSEcCtD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ALB—hematologic cancer	2.29e-05	0.000673	CbGpPWpGaD
Metolazone—Insomnia—Methotrexate—hematologic cancer	2.28e-05	0.000118	CcSEcCtD
Metolazone—Arthralgia—Doxorubicin—hematologic cancer	2.28e-05	0.000117	CcSEcCtD
Metolazone—Chest pain—Doxorubicin—hematologic cancer	2.28e-05	0.000117	CcSEcCtD
Metolazone—Anxiety—Doxorubicin—hematologic cancer	2.27e-05	0.000117	CcSEcCtD
Metolazone—Nausea—Triamcinolone—hematologic cancer	2.27e-05	0.000117	CcSEcCtD
Metolazone—Paraesthesia—Methotrexate—hematologic cancer	2.27e-05	0.000117	CcSEcCtD
Metolazone—CA5A—Metabolism—GSTP1—hematologic cancer	2.26e-05	0.000666	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—EP300—hematologic cancer	2.25e-05	0.000663	CbGpPWpGaD
Metolazone—Discomfort—Doxorubicin—hematologic cancer	2.25e-05	0.000116	CcSEcCtD
Metolazone—Anorexia—Epirubicin—hematologic cancer	2.25e-05	0.000116	CcSEcCtD
Metolazone—CA4—Metabolism—GSTT1—hematologic cancer	2.25e-05	0.000662	CbGpPWpGaD
Metolazone—Somnolence—Methotrexate—hematologic cancer	2.24e-05	0.000116	CcSEcCtD
Metolazone—Dry mouth—Doxorubicin—hematologic cancer	2.23e-05	0.000115	CcSEcCtD
Metolazone—Hypersensitivity—Prednisone—hematologic cancer	2.23e-05	0.000115	CcSEcCtD
Metolazone—Dyspepsia—Methotrexate—hematologic cancer	2.22e-05	0.000114	CcSEcCtD
Metolazone—CA12—Metabolism—CYCS—hematologic cancer	2.22e-05	0.000653	CbGpPWpGaD
Metolazone—Vomiting—Betamethasone—hematologic cancer	2.21e-05	0.000114	CcSEcCtD
Metolazone—Vomiting—Dexamethasone—hematologic cancer	2.21e-05	0.000114	CcSEcCtD
Metolazone—CA9—Metabolism—UGT1A1—hematologic cancer	2.21e-05	0.000649	CbGpPWpGaD
Metolazone—CA12—Metabolism—HSP90AA1—hematologic cancer	2.21e-05	0.000649	CbGpPWpGaD
Metolazone—CA4—Metabolism—SDC1—hematologic cancer	2.2e-05	0.000647	CbGpPWpGaD
Metolazone—Decreased appetite—Methotrexate—hematologic cancer	2.2e-05	0.000113	CcSEcCtD
Metolazone—Rash—Betamethasone—hematologic cancer	2.19e-05	0.000113	CcSEcCtD
Metolazone—Rash—Dexamethasone—hematologic cancer	2.19e-05	0.000113	CcSEcCtD
Metolazone—Dermatitis—Dexamethasone—hematologic cancer	2.19e-05	0.000113	CcSEcCtD
Metolazone—Dermatitis—Betamethasone—hematologic cancer	2.19e-05	0.000113	CcSEcCtD
Metolazone—Fatigue—Methotrexate—hematologic cancer	2.18e-05	0.000112	CcSEcCtD
Metolazone—Headache—Betamethasone—hematologic cancer	2.17e-05	0.000112	CcSEcCtD
Metolazone—Headache—Dexamethasone—hematologic cancer	2.17e-05	0.000112	CcSEcCtD
Metolazone—Asthenia—Prednisone—hematologic cancer	2.17e-05	0.000112	CcSEcCtD
Metolazone—Pain—Methotrexate—hematologic cancer	2.16e-05	0.000111	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.15e-05	0.000111	CcSEcCtD
Metolazone—Shock—Doxorubicin—hematologic cancer	2.15e-05	0.000111	CcSEcCtD
Metolazone—CA9—Metabolism—SLC22A1—hematologic cancer	2.15e-05	0.000631	CbGpPWpGaD
Metolazone—CA9—Metabolism—CRABP1—hematologic cancer	2.15e-05	0.000631	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ABCB1—hematologic cancer	2.14e-05	0.00063	CbGpPWpGaD
Metolazone—Thrombocytopenia—Doxorubicin—hematologic cancer	2.14e-05	0.00011	CcSEcCtD
Metolazone—Pruritus—Prednisone—hematologic cancer	2.14e-05	0.00011	CcSEcCtD
Metolazone—Insomnia—Epirubicin—hematologic cancer	2.14e-05	0.00011	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—VEGFA—hematologic cancer	2.14e-05	0.000628	CbGpPWpGaD
Metolazone—Paraesthesia—Epirubicin—hematologic cancer	2.12e-05	0.000109	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—STAT3—hematologic cancer	2.11e-05	0.000622	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTP1—hematologic cancer	2.11e-05	0.000621	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTP1—hematologic cancer	2.11e-05	0.000621	CbGpPWpGaD
Metolazone—Somnolence—Epirubicin—hematologic cancer	2.1e-05	0.000108	CcSEcCtD
Metolazone—CA9—Metabolism—ALOX5—hematologic cancer	2.09e-05	0.000615	CbGpPWpGaD
Metolazone—Anorexia—Doxorubicin—hematologic cancer	2.08e-05	0.000107	CcSEcCtD
Metolazone—Feeling abnormal—Methotrexate—hematologic cancer	2.08e-05	0.000107	CcSEcCtD
Metolazone—Dyspepsia—Epirubicin—hematologic cancer	2.08e-05	0.000107	CcSEcCtD
Metolazone—CA5A—Metabolism—GSTM1—hematologic cancer	2.08e-05	0.000612	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NCOR1—hematologic cancer	2.08e-05	0.000612	CbGpPWpGaD
Metolazone—Diarrhoea—Prednisone—hematologic cancer	2.07e-05	0.000106	CcSEcCtD
Metolazone—Gastrointestinal pain—Methotrexate—hematologic cancer	2.06e-05	0.000106	CcSEcCtD
Metolazone—Nausea—Dexamethasone—hematologic cancer	2.06e-05	0.000106	CcSEcCtD
Metolazone—Nausea—Betamethasone—hematologic cancer	2.06e-05	0.000106	CcSEcCtD
Metolazone—Decreased appetite—Epirubicin—hematologic cancer	2.05e-05	0.000106	CcSEcCtD
Metolazone—Fatigue—Epirubicin—hematologic cancer	2.04e-05	0.000105	CcSEcCtD
Metolazone—CA9—Metabolism—NUP98—hematologic cancer	2.03e-05	0.000596	CbGpPWpGaD
Metolazone—Pain—Epirubicin—hematologic cancer	2.02e-05	0.000104	CcSEcCtD
Metolazone—Constipation—Epirubicin—hematologic cancer	2.02e-05	0.000104	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—MAPK3—hematologic cancer	2.02e-05	0.000594	CbGpPWpGaD
Metolazone—Urticaria—Methotrexate—hematologic cancer	2.01e-05	0.000103	CcSEcCtD
Metolazone—CA5B—Metabolism—ABCB1—hematologic cancer	2e-05	0.000588	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCB1—hematologic cancer	2e-05	0.000588	CbGpPWpGaD
Metolazone—Dizziness—Prednisone—hematologic cancer	2e-05	0.000103	CcSEcCtD
Metolazone—Abdominal pain—Methotrexate—hematologic cancer	2e-05	0.000103	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.99e-05	0.000103	CcSEcCtD
Metolazone—Insomnia—Doxorubicin—hematologic cancer	1.98e-05	0.000102	CcSEcCtD
Metolazone—CA9—Metabolism—ADCY7—hematologic cancer	1.97e-05	0.000578	CbGpPWpGaD
Metolazone—CA9—Metabolism—NCOA3—hematologic cancer	1.97e-05	0.000578	CbGpPWpGaD
Metolazone—Paraesthesia—Doxorubicin—hematologic cancer	1.96e-05	0.000101	CcSEcCtD
Metolazone—CA12—Metabolism—GSTP1—hematologic cancer	1.96e-05	0.000576	CbGpPWpGaD
Metolazone—CA9—Metabolism—NUP214—hematologic cancer	1.95e-05	0.000574	CbGpPWpGaD
Metolazone—Feeling abnormal—Epirubicin—hematologic cancer	1.95e-05	0.0001	CcSEcCtD
Metolazone—Somnolence—Doxorubicin—hematologic cancer	1.94e-05	0.0001	CcSEcCtD
Metolazone—CA5B—Metabolism—GSTM1—hematologic cancer	1.94e-05	0.000571	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTM1—hematologic cancer	1.94e-05	0.000571	CbGpPWpGaD
Metolazone—CA7—Metabolism—NCOR1—hematologic cancer	1.94e-05	0.000571	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NCOR1—hematologic cancer	1.94e-05	0.000571	CbGpPWpGaD
Metolazone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.93e-05	9.95e-05	CcSEcCtD
Metolazone—Dyspepsia—Doxorubicin—hematologic cancer	1.92e-05	9.91e-05	CcSEcCtD
Metolazone—Vomiting—Prednisone—hematologic cancer	1.92e-05	9.89e-05	CcSEcCtD
Metolazone—CA9—Metabolism—MTR—hematologic cancer	1.91e-05	0.000563	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCG2—hematologic cancer	1.91e-05	0.000563	CbGpPWpGaD
Metolazone—Rash—Prednisone—hematologic cancer	1.91e-05	9.81e-05	CcSEcCtD
Metolazone—Dermatitis—Prednisone—hematologic cancer	1.9e-05	9.8e-05	CcSEcCtD
Metolazone—Decreased appetite—Doxorubicin—hematologic cancer	1.9e-05	9.79e-05	CcSEcCtD
Metolazone—Headache—Prednisone—hematologic cancer	1.89e-05	9.75e-05	CcSEcCtD
Metolazone—Fatigue—Doxorubicin—hematologic cancer	1.89e-05	9.71e-05	CcSEcCtD
Metolazone—Urticaria—Epirubicin—hematologic cancer	1.88e-05	9.67e-05	CcSEcCtD
Metolazone—CA9—Metabolism—ENO2—hematologic cancer	1.88e-05	0.000552	CbGpPWpGaD
Metolazone—CA4—Metabolism—NQO1—hematologic cancer	1.87e-05	0.00055	CbGpPWpGaD
Metolazone—CA4—Metabolism—CD44—hematologic cancer	1.87e-05	0.00055	CbGpPWpGaD
Metolazone—Pain—Doxorubicin—hematologic cancer	1.87e-05	9.63e-05	CcSEcCtD
Metolazone—Constipation—Doxorubicin—hematologic cancer	1.87e-05	9.63e-05	CcSEcCtD
Metolazone—Abdominal pain—Epirubicin—hematologic cancer	1.87e-05	9.62e-05	CcSEcCtD
Metolazone—Hypersensitivity—Methotrexate—hematologic cancer	1.86e-05	9.58e-05	CcSEcCtD
Metolazone—CA12—Metabolism—ABCB1—hematologic cancer	1.85e-05	0.000545	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MTHFR—hematologic cancer	1.84e-05	0.000541	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTT1—hematologic cancer	1.82e-05	0.000535	CbGpPWpGaD
Metolazone—Asthenia—Methotrexate—hematologic cancer	1.81e-05	9.33e-05	CcSEcCtD
Metolazone—Feeling abnormal—Doxorubicin—hematologic cancer	1.8e-05	9.28e-05	CcSEcCtD
Metolazone—CA12—Metabolism—GSTM1—hematologic cancer	1.8e-05	0.000529	CbGpPWpGaD
Metolazone—CA12—Metabolism—NCOR1—hematologic cancer	1.8e-05	0.000529	CbGpPWpGaD
Metolazone—Nausea—Prednisone—hematologic cancer	1.79e-05	9.24e-05	CcSEcCtD
Metolazone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.79e-05	9.21e-05	CcSEcCtD
Metolazone—Pruritus—Methotrexate—hematologic cancer	1.79e-05	9.2e-05	CcSEcCtD
Metolazone—CA9—Metabolism—SDC1—hematologic cancer	1.78e-05	0.000523	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYCS—hematologic cancer	1.77e-05	0.000521	CbGpPWpGaD
Metolazone—CA4—Metabolism—HSP90AA1—hematologic cancer	1.76e-05	0.000518	CbGpPWpGaD
Metolazone—Hypersensitivity—Epirubicin—hematologic cancer	1.74e-05	8.97e-05	CcSEcCtD
Metolazone—Urticaria—Doxorubicin—hematologic cancer	1.74e-05	8.95e-05	CcSEcCtD
Metolazone—Abdominal pain—Doxorubicin—hematologic cancer	1.73e-05	8.9e-05	CcSEcCtD
Metolazone—Diarrhoea—Methotrexate—hematologic cancer	1.73e-05	8.9e-05	CcSEcCtD
Metolazone—CA5B—Metabolism—MTHFR—hematologic cancer	1.72e-05	0.000505	CbGpPWpGaD
Metolazone—CA7—Metabolism—MTHFR—hematologic cancer	1.72e-05	0.000505	CbGpPWpGaD
Metolazone—Asthenia—Epirubicin—hematologic cancer	1.7e-05	8.73e-05	CcSEcCtD
Metolazone—Pruritus—Epirubicin—hematologic cancer	1.67e-05	8.61e-05	CcSEcCtD
Metolazone—Dizziness—Methotrexate—hematologic cancer	1.67e-05	8.6e-05	CcSEcCtD
Metolazone—Diarrhoea—Epirubicin—hematologic cancer	1.62e-05	8.33e-05	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—TP53—hematologic cancer	1.61e-05	0.000475	CbGpPWpGaD
Metolazone—Hypersensitivity—Doxorubicin—hematologic cancer	1.61e-05	8.3e-05	CcSEcCtD
Metolazone—Vomiting—Methotrexate—hematologic cancer	1.61e-05	8.27e-05	CcSEcCtD
Metolazone—Rash—Methotrexate—hematologic cancer	1.59e-05	8.2e-05	CcSEcCtD
Metolazone—Dermatitis—Methotrexate—hematologic cancer	1.59e-05	8.19e-05	CcSEcCtD
Metolazone—CA12—Metabolism—MTHFR—hematologic cancer	1.59e-05	0.000468	CbGpPWpGaD
Metolazone—Headache—Methotrexate—hematologic cancer	1.58e-05	8.15e-05	CcSEcCtD
Metolazone—Asthenia—Doxorubicin—hematologic cancer	1.57e-05	8.08e-05	CcSEcCtD
Metolazone—Dizziness—Epirubicin—hematologic cancer	1.56e-05	8.05e-05	CcSEcCtD
Metolazone—CA4—Metabolism—GSTP1—hematologic cancer	1.56e-05	0.000459	CbGpPWpGaD
Metolazone—Pruritus—Doxorubicin—hematologic cancer	1.55e-05	7.97e-05	CcSEcCtD
Metolazone—CA5A—Metabolism—PIK3CG—hematologic cancer	1.54e-05	0.000454	CbGpPWpGaD
Metolazone—CA9—Metabolism—NQO1—hematologic cancer	1.51e-05	0.000445	CbGpPWpGaD
Metolazone—CA9—Metabolism—CD44—hematologic cancer	1.51e-05	0.000445	CbGpPWpGaD
Metolazone—Vomiting—Epirubicin—hematologic cancer	1.5e-05	7.74e-05	CcSEcCtD
Metolazone—Nausea—Methotrexate—hematologic cancer	1.5e-05	7.73e-05	CcSEcCtD
Metolazone—Diarrhoea—Doxorubicin—hematologic cancer	1.5e-05	7.71e-05	CcSEcCtD
Metolazone—Rash—Epirubicin—hematologic cancer	1.49e-05	7.67e-05	CcSEcCtD
Metolazone—Dermatitis—Epirubicin—hematologic cancer	1.49e-05	7.67e-05	CcSEcCtD
Metolazone—Headache—Epirubicin—hematologic cancer	1.48e-05	7.62e-05	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—IL6—hematologic cancer	1.48e-05	0.000435	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCB1—hematologic cancer	1.48e-05	0.000435	CbGpPWpGaD
Metolazone—Dizziness—Doxorubicin—hematologic cancer	1.45e-05	7.45e-05	CcSEcCtD
Metolazone—CA5B—Metabolism—PIK3CG—hematologic cancer	1.44e-05	0.000424	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CG—hematologic cancer	1.44e-05	0.000424	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTM1—hematologic cancer	1.43e-05	0.000422	CbGpPWpGaD
Metolazone—CA4—Metabolism—NCOR1—hematologic cancer	1.43e-05	0.000422	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CREBBP—hematologic cancer	1.43e-05	0.000421	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYCS—hematologic cancer	1.43e-05	0.000421	CbGpPWpGaD
Metolazone—CA9—Metabolism—HSP90AA1—hematologic cancer	1.42e-05	0.000418	CbGpPWpGaD
Metolazone—Nausea—Epirubicin—hematologic cancer	1.4e-05	7.23e-05	CcSEcCtD
Metolazone—Vomiting—Doxorubicin—hematologic cancer	1.39e-05	7.16e-05	CcSEcCtD
Metolazone—Rash—Doxorubicin—hematologic cancer	1.38e-05	7.1e-05	CcSEcCtD
Metolazone—Dermatitis—Doxorubicin—hematologic cancer	1.38e-05	7.09e-05	CcSEcCtD
Metolazone—Headache—Doxorubicin—hematologic cancer	1.37e-05	7.05e-05	CcSEcCtD
Metolazone—CA5A—Metabolism—PIK3CD—hematologic cancer	1.36e-05	0.000399	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALB—hematologic cancer	1.34e-05	0.000394	CbGpPWpGaD
Metolazone—CA7—Metabolism—CREBBP—hematologic cancer	1.34e-05	0.000393	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CREBBP—hematologic cancer	1.34e-05	0.000393	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CG—hematologic cancer	1.34e-05	0.000393	CbGpPWpGaD
Metolazone—Nausea—Doxorubicin—hematologic cancer	1.3e-05	6.69e-05	CcSEcCtD
Metolazone—CA5A—Metabolism—PIK3R1—hematologic cancer	1.28e-05	0.000377	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTHFR—hematologic cancer	1.27e-05	0.000373	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CD—hematologic cancer	1.27e-05	0.000373	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CD—hematologic cancer	1.27e-05	0.000373	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTP1—hematologic cancer	1.26e-05	0.000371	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALB—hematologic cancer	1.25e-05	0.000368	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALB—hematologic cancer	1.25e-05	0.000368	CbGpPWpGaD
Metolazone—CA12—Metabolism—CREBBP—hematologic cancer	1.24e-05	0.000364	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3R1—hematologic cancer	1.2e-05	0.000352	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3R1—hematologic cancer	1.2e-05	0.000352	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCB1—hematologic cancer	1.19e-05	0.000351	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CB—hematologic cancer	1.18e-05	0.000348	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CD—hematologic cancer	1.17e-05	0.000345	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALB—hematologic cancer	1.16e-05	0.000341	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTM1—hematologic cancer	1.16e-05	0.000341	CbGpPWpGaD
Metolazone—CA9—Metabolism—NCOR1—hematologic cancer	1.16e-05	0.000341	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3R1—hematologic cancer	1.11e-05	0.000326	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CB—hematologic cancer	1.1e-05	0.000325	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CB—hematologic cancer	1.1e-05	0.000325	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CG—hematologic cancer	1.06e-05	0.000313	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTHFR—hematologic cancer	1.02e-05	0.000301	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CB—hematologic cancer	1.02e-05	0.000301	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTEN—hematologic cancer	1.02e-05	0.000301	CbGpPWpGaD
Metolazone—CA4—Metabolism—CREBBP—hematologic cancer	9.87e-06	0.00029	CbGpPWpGaD
Metolazone—CA5A—Metabolism—EP300—hematologic cancer	9.75e-06	0.000287	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTEN—hematologic cancer	9.54e-06	0.000281	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTEN—hematologic cancer	9.54e-06	0.000281	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CD—hematologic cancer	9.36e-06	0.000275	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALB—hematologic cancer	9.24e-06	0.000272	CbGpPWpGaD
Metolazone—CA5B—Metabolism—EP300—hematologic cancer	9.1e-06	0.000268	CbGpPWpGaD
Metolazone—CA7—Metabolism—EP300—hematologic cancer	9.1e-06	0.000268	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTEN—hematologic cancer	8.84e-06	0.00026	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3R1—hematologic cancer	8.84e-06	0.00026	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CG—hematologic cancer	8.6e-06	0.000253	CbGpPWpGaD
Metolazone—CA12—Metabolism—EP300—hematologic cancer	8.43e-06	0.000248	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CB—hematologic cancer	8.16e-06	0.00024	CbGpPWpGaD
Metolazone—CA9—Metabolism—CREBBP—hematologic cancer	7.98e-06	0.000235	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CD—hematologic cancer	7.56e-06	0.000223	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALB—hematologic cancer	7.47e-06	0.00022	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CA—hematologic cancer	7.21e-06	0.000212	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3R1—hematologic cancer	7.14e-06	0.00021	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTEN—hematologic cancer	7.05e-06	0.000207	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CA—hematologic cancer	6.73e-06	0.000198	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CA—hematologic cancer	6.73e-06	0.000198	CbGpPWpGaD
Metolazone—CA4—Metabolism—EP300—hematologic cancer	6.72e-06	0.000198	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CB—hematologic cancer	6.59e-06	0.000194	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CA—hematologic cancer	6.24e-06	0.000184	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AKT1—hematologic cancer	5.89e-06	0.000173	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTEN—hematologic cancer	5.7e-06	0.000168	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AKT1—hematologic cancer	5.5e-06	0.000162	CbGpPWpGaD
Metolazone—CA7—Metabolism—AKT1—hematologic cancer	5.5e-06	0.000162	CbGpPWpGaD
Metolazone—CA9—Metabolism—EP300—hematologic cancer	5.43e-06	0.00016	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKT1—hematologic cancer	5.09e-06	0.00015	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CA—hematologic cancer	4.97e-06	0.000146	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKT1—hematologic cancer	4.06e-06	0.00012	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CA—hematologic cancer	4.02e-06	0.000118	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKT1—hematologic cancer	3.28e-06	9.66e-05	CbGpPWpGaD
